Although the rupee depreciation has been a cause of concern for the economy, pharma companies are going to benefit from it and post good earnings this quarter, believes Bino Pathiparampil, Vice President Research, Institutional Equities, IIFL.
first published: Jul 6, 2012 01:13 pm
A collection of the most-viewed Moneycontrol videos.
Nifty At Over 3-Month Low; Will The Bulls Make A Comeback?| Opening Bell Live
Small town, Big tech: Sridhar Vembu on Zoho’s rural push, AI Bubble, SaaS consolidation & many more
Live: DAVOS 2026 Day 5 Highlights: Elon Musk, AI Innovations & India’s Investment Pitch
Budget 2026 Decoded ? Key Terms You Must Know | Inflation, Taxes & Spending
